Tiffany Trowles
Psychiatric/Mental Health · Cordova, TNNPI 1578028239
Payments from drug & device makers
Across 208 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$773
- Alkermes, Inc.$575
- Neurocrine Biosciences, Inc.$415
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$354
- Takeda Pharmaceuticals U.S.A., Inc.$292
- Sunovion Pharmaceuticals Inc.$238
- plus $904 from 13 others
What the payments were for
- Food & beverage$3,50499%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $773 |
| Alkermes, Inc. | 20 | $575 |
| Neurocrine Biosciences, Inc. | 24 | $415 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $292 |
| Sunovion Pharmaceuticals Inc. | 14 | $238 |
| Teva Pharmaceuticals USA, Inc. | 2 | $226 |
| Vanda Pharmaceuticals Inc. | 14 | $199 |
| Indivior Inc. | 7 | $133 |
| Otsuka America Pharmaceutical, Inc. | 7 | $109 |
| Merck | 4 | $56 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Noven Therapeutics, LLC | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$459
- UZEDY$226
- INGREZZA$125
- CAPLYTA$117
- ARISTADA INITIO$115
How this compares
$3,551 in reported general payments places this provider in the 80th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $573 |
| Quetiapine Fumarate | 57 | $501 |
| Aripiprazole | 19 | $412 |
| Duloxetine Hcl | 33 | $303 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $281 |
| Propranolol Hcl | 32 | $199 |
| Mirtazapine | 17 | $194 |
| Olanzapine | 23 | $187 |
| Ziprasidone Hcl | 11 | $154 |
| Lamotrigine | 20 | $146 |
| Hydroxyzine Hcl | 14 | $137 |
| Clonazepam | 21 | $118 |
| Trazodone Hcl | 28 | $100 |
| Fluoxetine Hcl | 36 | $72 |
| Alprazolam | 19 | $38 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cordova
- Uthappa MukatiraCordova$44K
- Derrick MeadowCordova$34K
- John RedmondCordova$23K
- Mark HesselrodeCordova$9K
- Amanda WoodallCordova$8K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.